BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 20707656)

  • 1. Breast MRI as an adjunct to mammography: Does it really suffer from low specificity? A retrospective analysis stratified by mammographic BI-RADS classes.
    Benndorf M; Baltzer PA; Vag T; Gajda M; Runnebaum IB; Kaiser WA
    Acta Radiol; 2010 Sep; 51(7):715-21. PubMed ID: 20707656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
    Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
    Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study.
    Baltzer PA; Benndorf M; Dietzel M; Gajda M; Runnebaum IB; Kaiser WA
    AJR Am J Roentgenol; 2010 Jun; 194(6):1658-63. PubMed ID: 20489110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
    Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
    Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer-Aided Diagnosis in Multiparametric Magnetic Resonance Imaging Screening of Women With Extremely Dense Breasts to Reduce False-Positive Diagnoses.
    Verburg E; van Gils CH; Bakker MF; Viergever MA; Pijnappel RM; Veldhuis WB; Gilhuijs KGA
    Invest Radiol; 2020 Jul; 55(7):438-444. PubMed ID: 32149858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BI-RADS® 3 lesions at contrast-enhanced breast MRI: is an initial short-interval follow-up necessary?
    Bahrs SD; Baur A; Hattermann V; Hahn M; Vogel U; Claussen CD; Siegmann-Luz KC
    Acta Radiol; 2014 Apr; 55(3):260-5. PubMed ID: 23969262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI for the assessment of malignancy in BI-RADS 4 mammographic microcalcifications.
    Bennani-Baiti B; Dietzel M; Baltzer PA
    PLoS One; 2017; 12(11):e0188679. PubMed ID: 29190656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of assigned BI-RADS breast density category definitions.
    Nicholson BT; LoRusso AP; Smolkin M; Bovbjerg VE; Petroni GR; Harvey JA
    Acad Radiol; 2006 Sep; 13(9):1143-9. PubMed ID: 16935726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging of the breast as a problem-solving method: to be or not to be?
    Oztekin PS; Kosar PN
    Breast J; 2014; 20(6):622-31. PubMed ID: 25200378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced breast MRI in patients with suspicious microcalcifications on mammography: results of a multicenter trial.
    Bazzocchi M; Zuiani C; Panizza P; Del Frate C; Soldano F; Isola M; Sardanelli F; Giuseppetti GM; Simonetti G; Lattanzio V; Del Maschio A
    AJR Am J Roentgenol; 2006 Jun; 186(6):1723-32. PubMed ID: 16714666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
    Strobel K; Schrading S; Hansen NL; Barabasch A; Kuhl CK
    Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of breast MRI for BI-RADS category 4B mammographic microcalcification: based on the 5
    Eun NL; Son EJ; Gweon HM; Youk JH; Kim JA
    Clin Radiol; 2018 Aug; 73(8):750-755. PubMed ID: 29853301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with x-ray mammography and whole-breast ultrasound.
    Pediconi F; Catalano C; Roselli A; Dominelli V; Cagioli S; Karatasiou A; Pronio A; Kirchin MA; Passariello R
    Invest Radiol; 2009 Jul; 44(7):412-21. PubMed ID: 19448554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between breast MRI and contrast-enhanced spectral mammography.
    Łuczyńska E; Heinze-Paluchowska S; Hendrick E; Dyczek S; Ryś J; Herman K; Blecharz P; Jakubowicz J
    Med Sci Monit; 2015 May; 21():1358-67. PubMed ID: 25963880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR imaging in probably benign lesions (BI-RADS category 3) of the breast.
    Gökalp G; Topal U
    Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Predictive Value of BI-RADS 3, 4, and 5 Lesions Detected on Breast MRI: Correlation with Study Indication.
    Chikarmane SA; Tai R; Meyer JE; Giess CS
    Acad Radiol; 2017 Apr; 24(4):435-441. PubMed ID: 27955878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of breast density on computer-aided detection (CAD) of breast cancer].
    Yang KY; Liu XJ; Zhai RY
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):360-3. PubMed ID: 22883457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
    Uematsu T; Yuen S; Kasami M; Uchida Y
    Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast tomosynthesis for the clarification of mammographic BI-RADS 3 lesions can decrease follow-up examinations and enables immediate cancer diagnosis.
    Bahrs SD; Otto V; Hattermann V; Klumpp B; Hahn M; Nikolaou K; Siegmann-Luz K
    Acta Radiol; 2018 Oct; 59(10):1176-1183. PubMed ID: 29451022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximum intensity breast diffusion MRI for BI-RADS 4 lesions detected on X-ray mammography.
    Bickelhaupt S; Paech D; Laun FB; Steudle F; Kuder TA; Mlynarska A; Bach M; Lederer W; Teiner S; Schneider S; Ladd ME; Daniel H; Stieber A; Kopp-Schneider A; Delorme S; Schlemmer HP
    Clin Radiol; 2017 Oct; 72(10):900.e1-900.e8. PubMed ID: 28687167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.